Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2025-12-25 @ 8:39 PM
Study NCT ID:
NCT02867592
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-02
First Post:
2016-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-27
Completion Date Type:
ESTIMATED
First Submit Date:
2016-08-15
First Submit QC Date:
None
Study First Post Date:
2016-08-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-08-11
Results First Submit QC Date:
None
Results First Post Date:
2022-11-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-12-02
Last Update Post Date Type:
ESTIMATED